<p><b>BACKGROUND</b>Few studies have examined the properties of
human immunodeficiency virus type 1 (
HIV-1 )
epitope -specific
cytotoxic T lymphocyte (CTL) responses in
children . To
address this issue, we characterized
epitope -specific CTL responses and analyzed the determinants that may
affect CTL responses before and after
highly active antiretroviral therapy (
HAART ) in
children with
HIV-1 infection .</p><p><b>
METHODS </b>A total of 22
HIV-1 -infected
children and 23 uninfected healthy
children as control were enrolled in the study. Circulating CD4
T cells and
HIV-1 RNA load in
plasma were routinely measured. Peripheral
HIV-1 -specific CTL frequency and
HIV-1 epitope -specific,
interferon-gamma (IFN-gamma)-producing
T lymphocytes were measured using tetramer
staining and enzyme-linked immunospot (
ELISPOT ) assay, respectively. Circulating
dendritic cell (DC) subsets were monitored with FACS
analysis .</p><p><b>RESULTS</b>More than 80% of the
children with
HIV-1 infection exhibited a positive
HIV-1 -
epitope -specific CTL response at baseline, but
HIV -specific CTLs and IFN-gamma-producing
lymphocytes decreased in
patients who responded to
HAART in comparison with non-responders and
HAART -naive
children . The duration of
virus suppression resulted from
HAART was inversely correlated with CTL frequency. While in
HAART -naive
children ,
HIV-1 -specific CTL frequency was positively correlated with myeloid DC (mDC) frequency, although the cause and effect relationship between the DCs and CTLs remains unknown.</p><p><b>CONCLUSIONS</b>
HIV-1 -
epitope -specific CTL responses are dependent on antigenic stimulation. The impaired DC subsets in
blood might result in a defect in DC-mediated
T cell responses. These findings may provide insight into
understanding the factors and related mechanisms that influence the outcome of
HIV-1 carriers to
HAART or
future antiviral therapies .</p>